- Filed
- Oct 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 1, 2025 | 190.01M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 184.8M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 184.37M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $55.2M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $44.05M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $55.2M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $44.05M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $5.43K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $120.15K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $5.43K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $120.15K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$94.6K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$36.08M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$36.2M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $45.56K |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$655.35K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$363.83K |